C22H27ClFN7O4S
540 g/mol
원료의약품위험
Encorafenib
CAS1269440-17-6
용도 분류
원료의약품
화합물 분류
헤테로사이클
주요 용도
의약 원료
Encorafenib is a small molecule compound that functions as a BRAF inhibitor, targeting key enzymes in the MAPK signaling pathway. It is supplied as a pharmaceutical raw material for use in research and manufacturing of cancer therapies.
Pharmaceutical manufacturingResearch compound for MAPK pathway studiesAPI for melanoma drug formulations
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1269440-17-6
관련 화합물
유사구조 유사유사도 0.77
Methyl (S)-(1-((4-(3-(3-amino-5-chloro-2-fluorophenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
CAS1269440-78-9
pharmaceutical intermediate
참고동일 카테고리
Pyrotinib
CAS1269662-73-8
HER2 inhibitor
참고동일 카테고리
Hydroxyurea
CAS127-07-1
Antineoplastic active pharmaceutical ingredient
참고동일 카테고리
Sodium sulfacetamide
CAS127-56-0
sulfonamide antibiotic active ingredient
참고동일 카테고리
SULFAMERAZINE SODIUM
CAS127-58-2
Sulfonamide antibacterial active ingredient
안전 참조
위험
H351Suspected of causing cancer
H360May damage fertility or the unborn child
H361Suspected of damaging fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure
H373May cause damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
H411Toxic to aquatic life with long lasting effects
식별자
IUPAC 이름
methyl N-[(2S)-1-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-propan-2-ylpyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate
InChIKey
CMJCXYNUCSMDBY-ZDUSSCGKSA-N
SMILES
C[C@@H](CNC1=NC=CC(=N1)C2=CN(N=C2C3=C(C(=CC(=C3)Cl)NS(=O)(=O)C)F)C(C)C)NC(=O)OC
동의어 목록 (21)
- Encorafenib (JAN/USAN/INN)
- Braftovi
- Braftovi (TN)
- Encorafenib
- Encorafenib (LGX818)
- Encorafenib (Standard)
- Encorafenib Refrence standard
- LGX-818(Encorafenib)
- LY2606368 mesylate
- US9314464, 9
- encorafenibum